Idecabtagene vicleucel for treating relapsed and refractory multiple myeloma after 3 or more treatments (terminated appraisal)

Technology appraisal
Reference number: TA936
Published: 30 November 2023

History

Invitation to participate

Final scope (PDF 199 KB)

Published:

06 October 2020
Final stakeholder list (PDF 195 KB)

Published:

06 October 2020
Equality impact assessment (Scoping) (PDF 123 KB)

Published:

06 October 2020
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 290 KB)

Published:

06 October 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators

Draft scope post referral (PDF 218 KB)

Published:

17 July 2020
Draft matrix post referral (PDF 193 KB)

Published:

17 July 2020